Head-to-head · WeighScore
Cora Health vs Midi Health
The verdict
Cora Health takes it — 72.5/100 to 56.4/100.
Cora Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Cora Health | Midi Health |
|---|---|---|
| WeighScore | 72.5/100 | 56.4/100 |
| Grade | C | C |
| Scorecard rank | #76 | #413 |
| Semaglutide | $175/mo | Not disclosed |
| Tirzepatide | $225/mo | Not disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #76 · C
Strengths
- Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
- Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
- LegitScript Certified (seal ID 49690100 in footer)
- Flat per-tier pricing — no dose-escalation surcharge
- Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide
Where it loses points
- Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
- Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
- Lowest advertised prices require 12-month commitment with no partial refunds
- No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
- Founder names and funding undisclosed on site
Graded #413 · C
Strengths
- Available in all 50 states
- Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
- Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
- Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)
Where it loses points
- Does not accept Medicare, Medicaid, or Medi-Cal
- GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
- Menopause-focused — not the right fit for men or younger women whose main goal is weight loss
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.